In turn, insulin resistance exacerbates the condition by impairing insulin's antilipolytic effects, resulting in increased plasma FFAs (Sun et al., 2021; Yao et al., 2022; Muniyappa, 2024). This evidence concerns the gene INS and Insulin resistance.